Twenty-five lots of eye ointments are being pulled from CVS, Walmart and two other distributors because of a sterility risk, the FDA said Feb. 26.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Twenty-five lots of eye ointments are being pulled from CVS, Walmart and two other distributors because of a sterility risk, the FDA said Feb. 26.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis